Clinical Trials Logo

Motor Seizure clinical trials

View clinical trials related to Motor Seizure.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04158531 Recruiting - Clinical trials for Epilepsy Intractable

REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.

REC2Stim
Start date: November 4, 2019
Phase: N/A
Study type: Interventional

People with central lobe epilepsy (CLE), with seizures arising from the primary sensorimotor cortex, typically show a high rate of convulsive seizures that do not respond to anti-epileptic drugs, but have a large impact on quality of life. They often seek surgical relief, but since the area contains the body's indispensable sensorimotor representation, CLE surgery will lead to permanent functional deficits. Cortical stimulation case studies in CLE have shown seizure frequency reduction of more than 90%, but in our experience, stimuli in the central lobe can hardly be applied without interfering with motor function. The investigators propose cortical electrical stimulation therapy of a conceptually novel type. The investigators systematically determine individual stimulation settings, stimulation site and a seizure detection algorithm. In REC2Stim (Rational Extra-eloquent Closed-loop Cortical Stimulation), at the start of a seizure, a train of electric pulses is delivered to a nearby extra-eloquent area connected with the epileptogenic area within the sensorimotor cortex. Success will constitute a therapeutic modality for pharmaco-resistant patients with an epileptic focus in eloquent areas.